Are adherens junctions implicated in the transition from physiological to pathological cardiac hypertrophy?

被引：0
|
作者：
Prado, Cibele M. [1 ]
Blefari, Valdecir [1 ]
Santos, Daniele O. [1 ]
Malvestio, Lygia M. M. [1 ]
Pedro, Rubens F. [1 ]
Rossi, Marcos M. [1 ]
机构：
[1] Univ Sao Paulo, BR-14049 Ribeirao Preto, Brazil
来源：
FASEB JOURNAL | 2013年 / 27卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
745.6
引用
收藏
页数：1
相关论文
共 50 条
  • [1] IS DYSTROPHIN ABSENCE IMPLICATED IN THE TRANSITION FROM PHYSIOLOGICAL TO PATHOLOGICAL CARDIAC HYPERTROPHY?
    Prado, C.
    Blefari, V.
    Oliveira, D.
    Silva, C. A.
    Fazan, R.
    Salgado, H. C.
    Rossi, M. A.
    HEART, 2013, 99 : A132 - A132
  • [2] Mechanisms for the transition from physiological to pathological cardiac hypertrophy
    Oldfield, Christopher J.
    Duhamel, Todd A.
    Dhalla, Naranjan S.
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2020, 98 (02) : 74 - 84
  • [3] Physiological and pathological cardiac hypertrophy
    Shimizu, Ippei
    Minamino, Tohru
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2016, 97 : 245 - 262
  • [4] Mechanisms of physiological and pathological cardiac hypertrophy
    Michinari Nakamura
    Junichi Sadoshima
    Nature Reviews Cardiology, 2018, 15 : 387 - 407
  • [5] Mechanisms of physiological and pathological cardiac hypertrophy
    Nakamura, Michinari
    Sadoshima, Junichi
    NATURE REVIEWS CARDIOLOGY, 2018, 15 (07) : 387 - 407
  • [6] The Impact of Adherens and Tight Junctions on Physiological Function and Pathological Changes in the Retina
    Kong, Yang
    Naggert, Jurgen K.
    Nishina, Patsy M.
    RETINAL DEGENERATIVE DISEASES: MECHANISMS AND EXPERIMENTAL THERAPY, 2018, 1074 : 545 - 551
  • [7] Resveratrol prevents pathological but not physiological cardiac hypertrophy
    Vernon W. Dolinsky
    Carrie-Lynn M. Soltys
    Kyle J. Rogan
    Anita Y. M. Chan
    Jeevan Nagendran
    Shaohua Wang
    Jason R. B. Dyck
    Journal of Molecular Medicine, 2015, 93 : 413 - 425
  • [8] Resveratrol prevents pathological but not physiological cardiac hypertrophy
    Dolinsky, Vernon W.
    Soltys, Carrie-Lynn M.
    Rogan, Kyle J.
    Chan, Anita Y. M.
    Nagendran, Jeevan
    Wang, Shaohua
    Dyck, Jason R. B.
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2015, 93 (04): : 413 - 425
  • [9] Pathological vs. physiological cardiac hypertrophy
    Kavazis, Andreas N.
    JOURNAL OF PHYSIOLOGY-LONDON, 2015, 593 (17): : 3767 - 3767
  • [10] Transcriptional profiles in physiological and pathological cardiac hypertrophy
    Rodrigo, MC
    Collier, M
    Uezato, H
    Deng, D
    Bristow, J
    Simpson, PC
    CIRCULATION, 2002, 106 (19) : 34 - 34
12345